Precision BioSciences, Inc. (DTIL)

NASDAQ: DTIL · Real-Time Price · USD

7.58

+0.35 (4.84%)

At close: May 26, 2026, 4:00 PM EDT

7.50

-0.08 (-1.06%)

After-hours: May 26, 2026, 7:37 PM EDT

Precision BioSciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	45.07	34.26	68.7	48.73	25.1	115.53
Revenue Growth (YoY)	-11.87%	-50.12%	40.98%	94.15%	-78.28%	375.72%
Gross Profit	45.07	34.26	68.7	48.73	25.1	115.53
Selling, General & Admin	-30.49	-32.24	-35.3	-39.09	-41.28	-39.67
Research & Development	-53.69	-54.17	-59.56	-53.38	-46.12	-115.24
Other Operating Expenses	0.04	0.04	-	-	-	-
Total Operating Expenses	-84.15	-86.38	-94.86	-92.46	-87.41	-154.91
Operating Income	129.22	120.64	163.55	141.19	112.5	270.43
Total Non-Operating Income (Expense)	-5.37	5.54	33.33	1.21	-10.6	8.77
Pretax Income	123.85	126.18	196.88	142.4	101.9	279.21
Net Income	-18.44	-45.72	7.17	142.4	-111.64	-30.6
Earnings From Discontinued Operations	0.89	0.89	-	-	-	-
Net Income to Common	-18.44	-45.72	7.17	142.4	-111.64	-30.6
Net Income Growth	-	-	-94.97%	-	-	-
Shares Outstanding (Basic)	17	13	7	4	3	2
Shares Outstanding (Diluted)	17	13	7	4	3	2
Shares Change (YoY)	111.05%	86.32%	79.20%	31.11%	49.77%	12.79%
EPS (Basic)	-3.66	-3.56	1.05	-15.96	-38.10	-15.60
EPS (Diluted)	-3.67	-3.56	1.04	-15.96	-38.10	-15.60
Shares Outstanding	25.81	24.09	8.2	4.19	3.7	2.03
Free Cash Flow	-58.77	-65.93	-58.7	-86.07	-49.07	-15.91
Free Cash Flow Per Share	-3.53	-5.14	-8.53	-22.41	-16.75	-8.13
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	286.69%	352.09%	238.08%	289.76%	448.26%	234.08%
Profit Margin	274.77%	368.25%	286.60%	292.24%	406.02%	241.68%
FCF Margin	-130.38%	-192.41%	-85.44%	-176.64%	-195.52%	-13.77%
EBITDA	130.59	122.11	166.96	148.01	120.3	279.42
EBITDA Margin	289.74%	356.37%	243.04%	303.75%	479.33%	241.86%
EBIT	129.22	120.64	163.55	141.19	112.5	270.43
EBIT Margin	286.69%	352.09%	238.08%	289.76%	448.26%	234.08%

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q